Kidneys filter waste products, excess water, and other impurities from your blood. These waste products are stored in your ...

In a new study, researchers evaluated the treatment effects of BI655064, an anti-CD40 monoclonal antibody, as an add-on ...

Patients that receive heart transplants with DCD hearts have comparable early renal outcomes to patients that receive hearts donated after brain death.

Age and waist circumference were significantly linked to the estimated glomerular filtration rate (eGFR). Investigators ...

Chronic kidney disease was defined as an estimated glomerular filtration rate (eGFR) of less than 60 mL/min/1.73 m² on 2 consecutive assessments separated by at least 3 months. Time-dependent Cox ...

GLP-1 agonists substantially slowed kidney deterioration and failure, independent of diabetes status. The most extensive and ...

As per Intent Market Research, the Cystatin C Assay Market was valued at USD 357 million in 2023 and will surpass USD 571 ...

Vivoryon Therapeutics N.V. Reports Q3 2024 Results and Highlights Progress on Varoglutamstat in Kidney Disease Varoglutamstat Phase 2 program shows highly consistent, statistically significant and ...

Rising blood levels of inflammatory marker neutrophil-to-lymphocyte ratio are linked to poorer outcomes with chronic kidney ...

Investigators studied the prevalence, predictors, and outcomes of complete functional recovery after radical nephrectomy.

Vivoryon Therapeutics’ glutaminyl cyclase inhibitor has failed a second phase 2 Alzheimer’s disease study this year, leaving ...

MIND Strongly Supporting Varoglutamstat’s Potential toImprove Kidney Function VIVA-MIND Phase 2 data confirm results of varoglutamstat’s benefit on eGFR in VIVIAD; Company now has two independent doub ...